SAFE ORTHOPAEDICS SA (ALSAF.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:ALSAF • FR001400ZU25

0.84 EUR
-0.1 (-10.63%)
Last: Feb 3, 2026, 07:00 PM
Fundamental Rating

1

ALSAF gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 68 industry peers in the Health Care Equipment & Supplies industry. ALSAF may be in some trouble as it scores bad on both profitability and health. ALSAF is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year ALSAF has reported negative net income.
  • In the past year ALSAF has reported a negative cash flow from operations.
  • ALSAF had negative earnings in each of the past 5 years.
  • In the past 5 years ALSAF reported 4 times negative operating cash flow.
ALSAF.PA Yearly Net Income VS EBIT VS OCF VS FCFALSAF.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -22350.40%, ALSAF is doing worse than 97.06% of the companies in the same industry.
Industry RankSector Rank
ROA -22350.4%
ROE N/A
ROIC N/A
ROA(3y)-5930.98%
ROA(5y)-3579.18%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALSAF.PA Yearly ROA, ROE, ROICALSAF.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10K -10K 20K

1.3 Margins

  • ALSAF has a worse Gross Margin (50.80%) than 61.76% of its industry peers.
  • ALSAF's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ALSAF so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.39%
GM growth 5Y14.07%
ALSAF.PA Yearly Profit, Operating, Gross MarginsALSAF.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K

More info and screens

0

2. Health

2.1 Basic Checks

  • ALSAF does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ALSAF has been increased compared to 1 year ago.
  • ALSAF has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ALSAF has an improved debt to assets ratio.
ALSAF.PA Yearly Shares OutstandingALSAF.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20K 40K 60K 80K 100K
ALSAF.PA Yearly Total Debt VS Total AssetsALSAF.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • Based on the Altman-Z score of -13.39, we must say that ALSAF is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -13.39, ALSAF is doing worse than 89.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -13.39
ROIC/WACCN/A
WACC3.69%
ALSAF.PA Yearly LT Debt VS Equity VS FCFALSAF.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M -200M

2.3 Liquidity

  • A Current Ratio of 0.20 indicates that ALSAF may have some problems paying its short term obligations.
  • ALSAF has a Current ratio of 0.20. This is amonst the worse of the industry: ALSAF underperforms 97.06% of its industry peers.
  • A Quick Ratio of 0.04 indicates that ALSAF may have some problems paying its short term obligations.
  • The Quick ratio of ALSAF (0.04) is worse than 97.06% of its industry peers.
Industry RankSector Rank
Current Ratio 0.2
Quick Ratio 0.04
ALSAF.PA Yearly Current Assets VS Current LiabilitesALSAF.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

1

3. Growth

3.1 Past

  • ALSAF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 99.51%, which is quite impressive.
  • ALSAF shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.24%.
  • The Revenue has been growing slightly by 1.42% on average over the past years.
EPS 1Y (TTM)99.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.87%
Revenue 1Y (TTM)-13.24%
Revenue growth 3Y3.44%
Revenue growth 5Y1.42%
Sales Q2Q%-3.07%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y14.29%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALSAF.PA Yearly Revenue VS EstimatesALSAF.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
ALSAF.PA Yearly EPS VS EstimatesALSAF.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100B -200B -300B -400B -500B

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • ALSAF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ALSAF is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALSAF.PA Price Earnings VS Forward Price EarningsALSAF.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALSAF.PA Per share dataALSAF.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -50K -100K -150K -200K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • ALSAF does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

SAFE ORTHOPAEDICS SA

EPA:ALSAF (2/3/2026, 7:00:00 PM)

0.84

-0.1 (-10.63%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)06-30
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap151.20K
Revenue(TTM)4.96M
Net Income(TTM)-1.77B
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-229246.54
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-20.41
FCFYN/A
OCF(TTM)-19.92
OCFYN/A
SpS27.56
BVpS-87.23
TBVpS-88.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -22350.4%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.8%
FCFM N/A
ROA(3y)-5930.98%
ROA(5y)-3579.18%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.39%
GM growth 5Y14.07%
F-Score3
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.2
Quick Ratio 0.04
Altman-Z -13.39
F-Score3
WACC3.69%
ROIC/WACCN/A
Cap/Depr(3y)39.29%
Cap/Depr(5y)87.91%
Cap/Sales(3y)5.82%
Cap/Sales(5y)15.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.87%
EPS Next Y14.29%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.24%
Revenue growth 3Y3.44%
Revenue growth 5Y1.42%
Sales Q2Q%-3.07%
Revenue Next Year11.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year7.84%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-105.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-105.05%
OCF growth 3YN/A
OCF growth 5YN/A

SAFE ORTHOPAEDICS SA / ALSAF.PA FAQ

What is the fundamental rating for ALSAF stock?

ChartMill assigns a fundamental rating of 1 / 10 to ALSAF.PA.


Can you provide the valuation status for SAFE ORTHOPAEDICS SA?

ChartMill assigns a valuation rating of 0 / 10 to SAFE ORTHOPAEDICS SA (ALSAF.PA). This can be considered as Overvalued.


Can you provide the profitability details for SAFE ORTHOPAEDICS SA?

SAFE ORTHOPAEDICS SA (ALSAF.PA) has a profitability rating of 1 / 10.


What is the earnings growth outlook for SAFE ORTHOPAEDICS SA?

The Earnings per Share (EPS) of SAFE ORTHOPAEDICS SA (ALSAF.PA) is expected to grow by 14.29% in the next year.